Vervloet MG - Search Results

1

Prevention and treatment of hyperphosphatemia in chronic kidney disease.

Vervloet MG, van Ballegooijen AJ. Vervloet MG, et al. Kidney Int. 2018 May;93(5):1060-1072. doi: 10.1016/j.kint.2017.11.036. Epub 2018 Mar 23. Kidney Int. 2018. PMID: 29580635 Free article. Review.

2

Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).

Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Lévesque R, Nubé MJ, Bots ML, Blankestijn PJ, ter Wee PM; CONTRAST Investigators. Penne EL, et al. Am J Kidney Dis. 2010 Jan;55(1):77-87. doi: 10.1053/j.ajkd.2009.09.023. Epub 2009 Dec 5. Am J Kidney Dis. 2010. PMID: 19962805 Clinical Trial.

3

Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort.

Vervloet MG, van Zuilen AD, Heijboer AC, ter Wee PM, Bots ML, Blankestijn PJ, Wetzels JF; MASTERPLAN group study. Vervloet MG, et al. BMC Nephrol. 2012 Apr 24;13:20. doi: 10.1186/1471-2369-13-20. BMC Nephrol. 2012. PMID: 22530966 Free PMC article.

4

Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease.

Bouma-de Krijger A, Bots ML, Vervloet MG, Blankestijn PJ, Ter Wee PW, van Zuilen AD, Wetzels JF. Bouma-de Krijger A, et al. Among authors: vervloet mg. Nephrol Dial Transplant. 2014 Jan;29(1):88-97. doi: 10.1093/ndt/gft456. Epub 2013 Nov 8. Nephrol Dial Transplant. 2014. PMID: 24215017 Clinical Trial.

5

Dietary and pharmacological modification of fibroblast growth factor-23 in chronic kidney disease.

Adema AY, de Borst MH, Ter Wee PM, Vervloet MG; NIGRAM Consortium. Adema AY, et al. Among authors: vervloet mg. J Ren Nutr. 2014 May;24(3):143-50. doi: 10.1053/j.jrn.2013.09.001. Epub 2013 Nov 9. J Ren Nutr. 2014. PMID: 24216259 Review.

6

Is chronic kidney disease-mineral bone disorder (CKD-MBD) really a syndrome?

Cozzolino M, Ureña-Torres P, Vervloet MG, Brandenburg V, Bover J, Goldsmith D, Larsson TE, Massy ZA, Mazzaferro S; CKD-MBD Working Group of ERA-EDTA. Cozzolino M, et al. Among authors: vervloet mg. Nephrol Dial Transplant. 2014 Oct;29(10):1815-20. doi: 10.1093/ndt/gft514. Epub 2014 Feb 9. Nephrol Dial Transplant. 2014. PMID: 24516228 Free article.

7

The role of klotho on vascular calcification and endothelial function in chronic kidney disease.

Vervloet MG, Adema AY, Larsson TE, Massy ZA. Vervloet MG, et al. Semin Nephrol. 2014 Nov;34(6):578-85. doi: 10.1016/j.semnephrol.2014.09.003. Semin Nephrol. 2014. PMID: 25498377 Review.

8

Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure.

van Breda F, Emans ME, van der Putten K, Braam B, van Ittersum FJ, Kraaijenhagen RJ, de Borst MH, Vervloet M, Gaillard CA. van Breda F, et al. PLoS One. 2015 Jun 16;10(6):e0128994. doi: 10.1371/journal.pone.0128994. eCollection 2015. PLoS One. 2015. PMID: 26079688 Free PMC article. Clinical Trial.

9

α-Klotho is unstable in human urine.

Adema AY, Vervloet MG, Blankenstein MA, Heijboer AC. Adema AY, et al. Among authors: vervloet mg. Kidney Int. 2015 Dec;88(6):1442-1444. doi: 10.1038/ki.2015.238. Epub 2015 Aug 5. Kidney Int. 2015. PMID: 26244922 Free article.

10

Dietary phosphorus restriction in predialysis chronic kidney disease: time for a cease-fire?

Evenepoel P, Vervloet MG. Evenepoel P, et al. Among authors: vervloet mg. Kidney Int. 2016 Jan;89(1):21-3. doi: 10.1016/j.kint.2015.11.006. Kidney Int. 2016. PMID: 26759042 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

213 results

Search Page

Filters